Thomas J. Polascik spends much of his time researching Prostate cancer, Surgery, Internal medicine, Prostate and Prostatectomy. His Prostate cancer research is classified as research in Cancer. The Surgery study combines topics in areas such as Renal cell carcinoma and Cryoablation.
His Internal medicine research is multidisciplinary, incorporating perspectives in Perioperative and Oncology. His biological study spans a wide range of topics, including Endocrinology and Pathology. His Prostatectomy research is multidisciplinary, relying on both Survival rate, Gynecology and Radiation therapy.
His primary scientific interests are in Prostate cancer, Internal medicine, Prostate, Surgery and Prostatectomy. His work deals with themes such as Biopsy, Radiology and Urology, which intersect with Prostate cancer. His work focuses on many connections between Urology and other disciplines, such as Proportional hazards model, that overlap with his field of interest in Hazard ratio.
He interconnects Gynecology, Oncology and MEDLINE in the investigation of issues within Internal medicine. Thomas J. Polascik has researched Prostate in several fields, including Stage and Disease, Pathology. His Surgery research integrates issues from Renal cell carcinoma, Nephrectomy and Cryoablation.
Thomas J. Polascik mainly focuses on Prostate cancer, Internal medicine, Oncology, Prostate and Radiology. Particularly relevant to Prostatectomy is his body of work in Prostate cancer. His study on Oncology also encompasses disciplines like
His studies deal with areas such as Interquartile range and Randomized controlled trial as well as Prostate. His Radiology research is multidisciplinary, relying on both Disease progression, MEDLINE and Multiparametric MRI. His Cryoablation study incorporates themes from Cryotherapy and Cryosurgery.
Prostate cancer, Internal medicine, Oncology, Prostate and Biopsy are his primary areas of study. His Prostate cancer study introduces a deeper knowledge of Cancer. His Hazard ratio, Proportional hazards model and Statin study in the realm of Internal medicine connects with subjects such as Glycated hemoglobin.
The Oncology study combines topics in areas such as Castration resistant and Germline mutation. His study looks at the intersection of Prostate and topics like Radiation therapy with Quartile, Urinary function and Androgen deprivation therapy. He usually deals with Biopsy and limits it to topics linked to Prostate biopsy and Ultrasound, Prostate-specific antigen, Cutoff point and Urology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
PROSTATE SPECIFIC ANTIGEN: A DECADE OF DISCOVERY-WHAT WE HAVE LEARNED AND WHERE WE ARE GOING
Thomas J. Polascik;Joseph E. Oesterling;Alan W. Partin.
The Journal of Urology (1999)
Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
P. Cairns;T. J. Polascik;Y. Eby;K. Tokino.
Nature Genetics (1995)
Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.
Timothy R. DeGrado;R. Edward Coleman;Shuyan Wang;Steven W. Baldwin.
Cancer Research (2001)
Satisfaction and Regret after Open Retropubic or Robot-Assisted Laparoscopic Radical Prostatectomy
Florian R. Schroeck;Tracey L. Krupski;Leon Sun;David M. Albala.
European Urology (2008)
The role of focal therapy in the management of localised prostate cancer: a systematic review
Massimo Valerio;Massimo Valerio;Hashim U Ahmed;Mark Emberton;Nathan L Lawrentschuk.
European Urology (2014)
Comparison of [18F]Fluorocholine and [18F]Fluorodeoxyglucose for Positron Emission Tomography of Androgen Dependent and Androgen Independent Prostate Cancer
David T. Price;R. Edward Coleman;Ray P. Liao;Cary N. Robertson.
The Journal of Urology (2002)
PILOT STUDY OF DIETARY FAT RESTRICTION AND FLAXSEED SUPPLEMENTATION IN MEN WITH PROSTATE CANCER BEFORE SURGERY: EXPLORING THE EFFECTS ON HORMONAL LEVELS, PROSTATE-SPECIFIC ANTIGEN, AND HISTOPATHOLOGIC FEATURES
Wendy Demark-Wahnefried;David T Price;Thomas J Polascik;Cary N Robertson.
Treatment of Localised Renal Cell Carcinoma
Hendrik Van Poppel;Frank Becker;Jeffrey A Cadeddu;Inderbir S Gill.
European Urology (2011)
Rationale for percutaneous biopsy and histologic characterisation of renal tumours.
Alessandro Volpe;Antonio Finelli;Inderbir S. Gill;Michael A.S. Jewett.
European Urology (2012)
Flaxseed Supplementation (Not Dietary Fat Restriction) Reduces Prostate Cancer Proliferation Rates in Men Presurgery
Wendy Demark-Wahnefried;Thomas J. Polascik;Stephen L. George;Boyd R. Switzer.
Cancer Epidemiology, Biomarkers & Prevention (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: